Další formáty:
BibTeX
LaTeX
RIS
@article{1441416, author = {Horská, Jana and Ginterová, Pavlína and Ševčík, Juraj and Petr, Jan}, article_location = {Praha}, article_number = {3}, keywords = {CHRONIC MYELOID-LEUKEMIA; IMATINIB MESYLATE}, language = {eng}, issn = {0009-2770}, journal = {Chemické Listy}, title = {A pilot study on separation of new drugs for treatment of leukemia by capillary zone electrophoresis}, volume = {107}, year = {2013} }
TY - JOUR ID - 1441416 AU - Horská, Jana - Ginterová, Pavlína - Ševčík, Juraj - Petr, Jan PY - 2013 TI - A pilot study on separation of new drugs for treatment of leukemia by capillary zone electrophoresis JF - Chemické Listy VL - 107 IS - 3 SP - 373-375 EP - 373-375 SN - 00092770 KW - CHRONIC MYELOID-LEUKEMIA KW - IMATINIB MESYLATE N2 - Imatinib, bosutinib, dasatinib, pazopanib, erlotinib, canertinib and vatalanib are new important anticancer drugs, especially for treatment chronic myeloid leukemia. All of these substances without imatinib are being tested in clinical trials with very promising results. Imatinib is the standard first-line therapy at chronic myeloid leukemia for almost 10 years. The aim of our work was to develop the fastest separation of all these drugs in one run. According to the structure of drugs, capillary zone electrophoresis was chosen. The separation was performed with a background electrolyte containing 100 mM phosphoric acid, adjusted by sodium hydroxide to pH 2.75. ER -
HORSKÁ, Jana, Pavlína GINTEROVÁ, Juraj ŠEVČÍK a Jan PETR. A pilot study on separation of new drugs for treatment of leukemia by capillary zone electrophoresis. \textit{Chemické Listy}. Praha, 2013, roč.~107, č.~3, s.~373-375. ISSN~0009-2770.
|